Active, Not Recruiting
Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow
NCT03363373
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
- Locations
-
- Riley Hospital for Children Indianapolis, Indiana, United States
- Memorial Sloan Kettering Cancer Center New York, United States
- The Hospital for Sick Children Toronto, Canada
- Rigshospitalet Copenhagen, Denmark